In ₹ Crore except Per Share Latest Annual | ORIENTCEM FY26 | AMBUJACEM FY26 | ULTRACEMCO FY26 | DALBHARAT FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | — | ◆ 20.70× | 39.45× | 28.86× | 28.86× | |
| P/B | — | ◆ 1.36× | 4.00× | 1.84× | 1.84× | |
| EV/EBITDA | — | 14.86× | 20.06× | ◆ 11.27× | 14.86× | |
| Market Cap | — | ₹97,982 Cr | ₹3.23L Cr | ₹33,298 Cr | ₹97,982 Cr | |
| Growth | ||||||
| Revenue CAGR 3Y | 0.82% | 7.03% | ◆ 11.86% | 3.02% | 7.03% -88% | |
| Revenue CAGR 5Y | — | 7.02% | ◆ 14.63% | 7.07% | 7.07% | |
| Net Income CAGR 3Y | — | 5.96% | ◆ 17.30% | 2.35% | 5.96% | |
| Revenue YoY (latest Q) | — | -7.67% | ◆ 15.85% | 6.99% | 6.99% | |
| Net Income YoY (latest Q) | — | -31.93% | ◆ 17.24% | -51.39% | -31.93% | |
| Profitability | ||||||
| EBITDA Margin | 19.53% | 16.08% | 19.23% | ◆ 20.83% | 19.23% +2% | |
| Net Income Margin | 12.09% | ◆ 13.87% | 9.25% | 7.82% | 9.25% +31% | |
| Return on Common Equity | ◆ 15.74% | 6.58% | 10.12% | 6.28% | 6.58% +139% | |
| Return on Capital Employed | — | 3.88% | ◆ 11.51% | 6.27% | 6.27% | |
| Return on Assets | ◆ 10.78% | 6.29% | 5.79% | 3.47% | 5.79% +86% | |
| Credit & Quality | ||||||
| Total Debt/Equity | — | ◆ 0.00× | 0.28× | 0.37× | 0.28× | |
| Interest Coverage | ◆ 24.70× | 13.28× | 6.61× | 3.61× | 6.61× +274% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹2,793 Cr | ₹40,656 Cr | ₹88,512 Cr | ₹14,804 Cr | ₹40,656 Cr -93% | |
| Net Income | ₹338 Cr | ₹5,637 Cr | ₹8,188 Cr | ₹1,157 Cr | ₹5,637 Cr -94% | |
| Total Assets | ₹3,133 Cr | ₹89,607 Cr | ₹1.41L Cr | ₹33,312 Cr | ₹89,607 Cr -97% | |
| EPS | — | ₹19.15 | ₹277.62 | ₹60.73 | ₹60.73 | |
| Book Value per Share | — | ₹290.66 | ₹2,738.99 | ₹953.84 | ₹953.84 | |